![Ingrid Delaet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 31/08/2026
Dr. Ingrid Delaet is a Chief Regulatory Officer at Neurocrine Biosciences, Inc. Dr. Delaet was previously employed as a Senior Vice President-Regulatory Affairs by Intercept Pharmaceuticals, Inc., a Global Regulatory Affairs by Bristol Myers Squibb Co., a Head-Clinical Research by CellPro, Inc., and a Head-Clinical Research by Wyeth-Ayerst Research.
She received her graduate degree from Université Libre de Bruxelles and a doctorate degree from Université Libre de Bruxelles.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/09/2026 | 18.289 ( 0,02 % ) | 3 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Consejero General | 01/01/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Consejero General | 01/01/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Consejero General | 01/09/2016 |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
CellPro, Inc.
 CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
CellPro, Inc.
CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth-Ayerst Research |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
